@misc{indiciae17dd4bc86cca,
  title = {Using CCDC6 immunostaining in conjunction with the RAD51 HRD assay as a novel approach to expand PARPi treatment eligibility in HGSOC patients},
  author = {Criscuolo, D. and Merolla, F. and Pellegrino, B. and Russolillo, L. and De Benedictis, I. and Califano, D. and Catalano, R. and Baviello, C. and Varricchio, S. and Cecere, S. C. and Nero, C. and Palluzzi, E. and Katsaros, D. and Capoluongo, E. D. and Scaglione, G. L. and Marchini, S. and Russo, D. and Spina, A. and Arenare, L. and Morra, F. and Marotta, M. and Vecchione, M. A. and Ingallinella, A. and Perrone, F. and Pignata, S. and CELETTI, A.},
  year = {2025},
  doi = {10.1101/2025.07.29.667411},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.29.667411v1},
  note = {Source identifier: 10.1101/2025.07.29.667411}
}